BioNano Genomics Inc vs Enveric Biosciences Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: BioNano Genomics Inc is far larger — about 2.2× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| BNGO | ENVB | |
|---|---|---|
Market Cap | $13.66M | $6.20M |
Sector | Health | Health |
52-Week High | $4.92 | $17.40 |
52-Week Low | $1.06 | $1.27 |
Enterprise Value | $16.26M | $1.30M |
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →